SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis
- 11 October 2021
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 24 (2) , 215-226
Abstract
The use of stereotactic body radiation therapy (SBRT) to treat non-spine bone metastases (NSBM) is becoming increasingly common in clinical practice. The clinical advantages of SBRT include good pain control and high local control rates, although only limited data are available. The Spanish Society of Radiation Oncology (SEOR) SBRT group recently convened a task force of experts in the field to address key questions related to SBRT for NSBM, including treatment indications, planning, techniques, and dose fractionation. The task force reviewed the available literature to develop evidence-based recommendations for the safe application of NSBM SBRT and to standardize and optimize SBRT processes. The present document provides a comprehensive analysis of the available data, including ongoing clinical trials and controversies, providing clinically applicable recommendations.Keywords
This publication has 70 references indexed in Scilit:
- Stereotactic body radiation therapy: The report of AAPM Task Group 101Medical Physics, 2010
- Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancerBritish Journal of Cancer, 2010
- Analysis of Patients With Oligometastases Undergoing Two or More Curative-Intent Stereotactic Radiotherapy CoursesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Bone marrow micrometastases in different solid tumors: Pathogenesis and importanceSurgical Oncology, 2008
- Pathologic fractures correlate with reduced survival in patients with malignant bone diseaseCancer, 2007
- Randomized trial of 8Gy in 1 versus 20Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05)Radiotherapy and Oncology, 2005
- Bone Imaging in Metastatic Breast CancerJournal of Clinical Oncology, 2004
- Metastatic Disease of the Femur: Surgical TreatmentClinical Orthopaedics and Related Research, 2003
- The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis StudyRadiotherapy and Oncology, 1999